OUTLOOK Historical Financial Ratios
| OTLK Stock | USD 2.01 0.31 18.24% |
OUTLOOK THERAPEUTICS is promptly reporting on over 104 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Invested Capital of 0.0 will help investors to properly organize and evaluate OUTLOOK THERAPEUTICS INC financial condition quickly.
OUTLOOK |
About OUTLOOK Financial Ratios Analysis
OUTLOOK THERAPEUTICS INCFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate OUTLOOK THERAPEUTICS investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on OUTLOOK financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across OUTLOOK THERAPEUTICS history.
OUTLOOK THERAPEUTICS Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing OUTLOOK THERAPEUTICS INC stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on OUTLOOK THERAPEUTICS sales, a figure that is much harder to manipulate than other OUTLOOK THERAPEUTICS INC multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is OUTLOOK THERAPEUTICS INC dividend as a percentage of OUTLOOK THERAPEUTICS stock price. OUTLOOK THERAPEUTICS INC dividend yield is a measure of OUTLOOK THERAPEUTICS stock productivity, which can be interpreted as interest rate earned on an OUTLOOK THERAPEUTICS investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Asset Turnover
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.Most ratios from OUTLOOK THERAPEUTICS's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into OUTLOOK THERAPEUTICS INC current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, OUTLOOK THERAPEUTICS's Days Payables Outstanding is quite stable compared to the past year. ROE is expected to rise to 1.08 this year, although Book Value Per Share is projected to rise to (3.7 K).
| 2017 | 2023 | 2024 (projected) | Dividend Yield | 13.2K | 11.9K | 12.5K | Price To Sales Ratio | 46.19 | 2.99 | 2.84 |
OUTLOOK THERAPEUTICS fundamentals Correlations
Click cells to compare fundamentals
OUTLOOK THERAPEUTICS Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OUTLOOK THERAPEUTICS fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 18.49 | 71.91 | 29.62 | (3.83) | (0.001355) | (0.001288) | |
| Book Value Per Share | 0.78 | 0.6 | 0.82 | (1.15) | (3.9K) | (3.7K) | |
| Operating Cash Flow Per Share | (8.76) | (7.11) | (5.34) | (3.44) | (3.7K) | (3.5K) | |
| Pb Ratio | 18.49 | 71.91 | 29.62 | (3.83) | (0.001355) | (0.001288) | |
| Free Cash Flow Per Share | (8.76) | (7.11) | (5.34) | (3.44) | (3.7K) | (3.5K) | |
| Roic | (4.56) | (3.15) | (3.21) | (2.52) | 0.99 | 1.03 | |
| Net Income Per Share | (9.71) | (6.96) | (6.23) | (4.72) | (4.1K) | (3.9K) | |
| Payables Turnover | 0.23 | 0.12 | 0.0586 | 0.006721 | 0.006049 | 0.005747 | |
| Cash Per Share | 3.46 | 1.9 | 1.64 | 1.87 | 804.77 | 845.01 | |
| Pocfratio | (1.64) | (6.11) | (4.57) | (1.29) | (0.00144) | (0.001512) | |
| Interest Coverage | (20.98) | (55.26) | (42.4) | (34.06) | (22.71) | (23.85) | |
| Pfcf Ratio | (1.64) | (6.11) | (4.57) | (1.29) | (0.00144) | (0.001512) | |
| Days Payables Outstanding | 1.6K | 3.1K | 6.2K | 54.3K | 62.5K | 88.3K | |
| Income Quality | 0.9 | 1.02 | 0.86 | 0.73 | 0.91 | 0.61 | |
| Roe | (12.47) | (11.54) | (7.56) | 4.09 | 1.03 | 1.08 | |
| Ev To Operating Cash Flow | (1.53) | (6.06) | (4.45) | (1.57) | 0.21 | 0.22 | |
| Pe Ratio | (1.48) | (6.23) | (3.92) | (0.94) | (0.001314) | (0.00138) | |
| Return On Tangible Assets | (1.79) | (2.33) | (2.32) | (1.83) | (2.61) | (2.75) | |
| Ev To Free Cash Flow | (1.53) | (6.06) | (4.45) | (1.57) | 0.21 | 0.22 | |
| Earnings Yield | (0.67) | (0.16) | (0.26) | (1.07) | (760.89) | (722.85) | |
| Net Debt To E B I T D A | (0.22) | 0.1 | 0.05 | (0.21) | 0.2 | 0.21 | |
| Current Ratio | 0.67 | 1.13 | 3.19 | 1.39 | 0.66 | 0.64 | |
| Tangible Book Value Per Share | 0.78 | 0.6 | 0.82 | (1.15) | (3.9K) | (3.7K) | |
| Graham Number | 13.05 | 9.72 | 10.75 | 11.07 | 19.0K | 19.9K | |
| Shareholders Equity Per Share | 0.78 | 0.6 | 0.82 | (1.15) | (3.9K) | (3.7K) | |
| Debt To Equity | 1.62 | 2.56 | 1.25 | (2.46) | (0.004076) | (0.004279) | |
| Graham Net Net | (1.2) | (0.49) | (0.23) | (1.87) | (4.7K) | (4.5K) | |
| Interest Debt Per Share | 1.74 | 1.67 | 1.17 | 2.97 | 186.25 | 94.57 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.06) | Revenue Per Share 0.119 | Quarterly Revenue Growth 6.583 | Return On Assets (0.84) | Return On Equity (0.04) |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.